Research Article
Design, Characterization, and Optimization of Controlled Drug Delivery System Containing Antibiotic Drug/s
Table 4
Formulation of osmotic tablet (F7–F12).
| | Ingredient | Batch number | | F7 | F8 | F9 | F10 | F11 | F12 |
| | Dicloxacillin sodium (mg) | 244 | 244 | 244 | 244 | 244 | 244 | | NaCl (mg) | 50 | 50 | 50 | 150 | 50 | 50 | | MCC (mg) | 30 | 90 | 90 | 90 | 30 | 90 | | SLS (mg) | 20 | 20 | 10 | 20 | 10 | 20 | | Sucrose (mg) | 50 | 90 | 90 | 30 | 90 | 30 | | PVP K30 (mg) | 15 | 15 | 15 | 15 | 15 | 15 | | EC (%) | 4 | 2 | 4 | 2 | 2 | 4 | | CA (%) | 4 | 2 | 2 | 2 | 4 | 2 | | PEG 400 (%) | 2 | 2 | 2 | 2 | 2 | 2 | | Magnesium stearate (mg) | 3 | 3 | 3 | 3 | 3 | 3 | | Talc (mg) | 3 | 3 | 3 | 3 | 3 | 3 | | Coloring agent | q.s | q.s | q.s | q.s | q.s | q.s |
|
|
